Featured

FDA Approves Insightec's Exablate Neuro for Staged Bilateral Treatment of Parkinson's Disease

Insightec announced FDA approval of its Exablate Neuro platform for staged bilateral pallidothalamic tractotomy in patients with advanced Parkinson's ...

Home/KnolSights/Regulatory Approvals/FDA Approves Insightec's Exablate Neuro for Staged Bilateral Treatment of Parkinson's Disease